Matthias Ocker
Impact in
-
- Nigella sativa pharmacological applications
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 21
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Liver physiology and pathology 5
-
- Histone Deacetylase Inhibitors Research 15
- Fibroblast Growth Factor Research 5
- Co-authors
- Regine Schneider‐Stock (11 shared papers)Daniel Neureiter (50 shared papers)Hala U. Gali‐Muhtasib (7 shared papers)Pietro Di Fazio (27 shared papers)Christoph Herold (20 shared papers)Marion Ganslmayer (16 shared papers)Karl Quint (18 shared papers)Detlef Schuppan (7 shared papers)
- Journals
- International Journal of Oncology (9 papers)Journal of Hepatology (5 papers)Expert Opinion on Investigational Drugs (5 papers)World Journal of Gastroenterology (5 papers)Oncology Reports (4 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Matthias Ocker
152 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 93
- Complementary and alternative medicine 325
- Hepatology 290
- Molecular Biology 1.4k
- Oncology 412
- Cancer Research 194
Countries citing papers authored by Matthias Ocker
This map shows the geographic impact of Matthias Ocker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Ocker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Ocker more than expected).
Fields of papers citing papers by Matthias Ocker
This network shows the impact of papers produced by Matthias Ocker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Ocker. The network helps show where Matthias Ocker may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthias Ocker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 153 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 244 | |
| 2 | 2007 | 225 | |
| 3 | 2009 | 196 | |
| 4 | 2020 | 178 | |
| 5 | 2002 | 165 | |
| 6 | 2019 | 148 | |
| 7 | 2007 | 145 | |
| 8 | 2008 | 143 | |
| 9 | 2002 | 135 | |
| 10 | 2009 | 129 | |
| 11 | 2012 | 116 | |
| 12 | 2017 | 116 | |
| 13 | 2009 | 108 | |
| 14 | 2011 | 105 | |
| 15 | 2011 | 103 | |
| 16 | 2012 | 89 | |
| 17 | 2019 | 89 | |
| 18 | 2008 | 88 | |
| 19 | 2005 | 76 | |
| 20 | 2013 | 75 |
About Matthias Ocker
Matthias Ocker is a scholar working on Hepatology, Molecular Biology, Oncology, Cell Biology and Surgery, having authored 153 papers that have together received 5.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Liver physiology and pathology (5 papers), Fibroblast Growth Factor Research (5 papers), Cannabis and Cannabinoid Research (4 papers), Cancer Cells and Metastasis (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Complementary and alternative medicine (325 citations), Hepatology (290 citations), Molecular Biology (1.4k citations), Oncology (412 citations) and Cancer Research (194 citations). Matthias Ocker has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Regine Schneider‐Stock, Daniel Neureiter, Hala U. Gali‐Muhtasib, Pietro Di Fazio, Christoph Herold, Marion Ganslmayer, Karl Quint, Detlef Schuppan, Eckhart G. Hahn and Roberta Montalbano. Their work appears in journals such as International Journal of Oncology, Journal of Hepatology, Expert Opinion on Investigational Drugs, World Journal of Gastroenterology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.